JS

James Shannon

North America, Pennsylvania, United States, Berwyn

Description

James Shannon, Chairman of the Board: Mannkind Corporation, myTomorrows & Kyowa Kirin (NA).

Investor Profile

James Shannon has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • The Netherlands (100%)

Industry Focus

  • Health Care
  • Medical
  • Analytics
  • Assistive Technology
  • Generative Ai
  • Life Science
  • Machine Learning
  • Pharmaceutical
  • Saas
  • Search Engine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does James Shannon frequently co-invest with?

Keen Venture Partners
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
DFF (Dutch Founders Fund)
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Slimmer AI
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1

Which angels does James Shannon often collaborate with?

David Meeker
North America, Massachusetts, United States, Boston
Shared Deals: 1
JM
North America, Massachusetts, United States, Boston
Shared Deals: 1
DA
Europe, Zuid-Holland, The Netherlands, Leiden
Shared Deals: 1
HG
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
OS
Europe, Zuid-Holland, The Netherlands, The Hague
Shared Deals: 1
DV
Europe, Zuid-Holland, The Netherlands, Leiden
Shared Deals: 2
JT
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
EK
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by James Shannon?

EvidenceHunt

Amsterdam, Noord-Holland, The Netherlands

EvidenceHunt is an AI-powered research platform that streamlines the process of gathering, analyzing and utilizing medical evidence.

AnalyticsAssistive TechnologyGenerative AIHealth CareLife ScienceMachine LearningMedicalPharmaceuticalSaaSSearch Engine
SeedFeb 26, 2025
Amount Raised: $1,259,685
Xinvento

Amsterdam, Noord-Holland, The Netherlands

Xinvento provides a credible alternative treatment for congenital hyperinsulinism.

Health CareMedical
SeedApr 21, 2022